3'-O-(2-Nitrobenzyl)-dTTP acts as a reversible terminator for DNA chain elongation. 3'-O-(2-Nitrobenzyl)-dTTP interacts with 9°N polymerase (exo-) A485L/Y409V, gets recognized and incorporated into the elongating DNA chain, thereby temporarily terminating the polymerase reaction. 3'-O-(2-Nitrobenzyl)-dTTP carries a 3'-O-(2-nitrobenzyl) blocking group, which can be removed by laser irradiation to regenerate the free 3'-OH− group and restore polymerase activity. 3'-O-(2-Nitrobenzyl)-dTTP is applicable in DNA sequencing studies.

3-Chloropropan-1-amine hydrochloride is a PROTAC linker that can be used in the synthesis of PROTACs.

3-(4-Bromophenyl)propanoic acid is a PROTAC linker that can be used in the synthesis of PROTACs.

2-Bromo-LSD D-Tartrate is a blood-brain barrier-permeable 5-HT2A partial agonist and competitive partial antagonist. 2-Bromo-LSD D-Tartrate acts as both a potent partial agonist (with an EC50 of 0.81 nM for Gq dissociation) and a potent partial antagonist (with a KB of 0.18 nM for Gq dissociation) at the 5-HT2A receptor. 2-Bromo-LSD D-Tartrate exhibits partial agonist activity at multiple aminergic GPCRs, including 5-HT2A. 2-Bromo-LSD D-Tartrate lacks 5-HT2B agonist activity. 2-Bromo-LSD D-Tartrate induces dendritogenesis and spinogenesis. 2-Bromo-LSD D-Tartrate reverses the behavioral effects of chronic stress and increases active coping behaviors in mice.

2-Bromo-5-Chloroterephthalic Acid (2-Bromo-5-chloroterephthalic acid) is a metal-organic framework (MOF).

1-Nonadecanoin-2,3-acetyl is an acylglycerol.

1-Heptanoyl-2,3-diacetyl is an acylglycerol.

1,3-Palmitin-2-vaccenoin is a triglyceride.

1,3-Myristin-2-octanoin is a fatty ester.

1,3-Linolenin-2-myristin is an acylglycerol.

1,3-Linolein-2-laurin is an acylglycerol.

1,3-Digamma linolenin is an acylglycerol.

1,3-Butyrin-2-palmitin is an acylglycerol.

1,2-Stearin-3-laurin is an acylglycerol.

1,2-Stearin-3-elaidin is an acylglycerol.

1,2-Palmitolein-3-eicosatrienoin is an acylglycerol.

1,2-Olein-3-butyrin is an acylglycerol.

1,2-Linolenin-3-stearin is an acylglycerol.

1,2-Linolenin-3-olein is an acylglycerol.

1,2-Linolenin-3-myristin is an acylglycerol.

1,2-Linolenin-3-laurin is an acylglycerol.

1,2-Laurin-3-palmitin is an acylglycerol.

1,2-Butyrin-3-stearin is an acylglycerol.

(S,S) Bisoleoyl-lysobisphosphatidic acid is a lysobisphosphatidic acid (LBPA). LBPA plays a role in modulating the cholesterol flux through endosomes.

(S,R,S)-AHPC-Me-amide-C-O-PEG2-COOH is an E3 ligase ligand-linker conjugate. (S,R,S)-AHPC-Me-amide-C-O-PEG2-COOH can be used for synthesis of PROTACs.

(S,R,S)-AHPC-CO-PEG3-NHBoc is a synthesized E3 ligase ligand-linker conjugate that can be used to synthesize PROTAC G9a/GLP degrader 1. PROTAC G9a/GLP degrader 1 is a potent G9a/GLP PROTAC degrader with anti-cancer activity.

(S)-Oxybutynin is a pharmaceutical intermediate. (S)-Oxybutynin can synthesize antifungal agents.

(S)-2-Ketodoxapram ((S)-AHR 5955) is a metabolite of Doxapram. Doxapram is a respiratory stimulant[1][2].

(rel)-Nutlin carboxylic acid is the Nutlin 3-based MDM2 ligand. (rel)-Nutlin carboxylic acid can be connected to the ligand for protein by a linker to form PROTAC.

(Rac)-Opnurasib ((Rac)-JDQ-443; (Rac)-NVP-JDQ443) is the levorotomer of Opnurasib. Opnurasib is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). Opnurasib shows antitumor activity.